Supported by world-class markets data from Dow Jones and FactSet, and partnering with Automated Insights, MarketWatch ...
The results of the Intuition Brain Health study – sponsored by Biogen and supported by Apple – show the feasibility of using ...
NICE has upheld its decision not to recommend Alzheimer's treatments donanemab and lecanemab for NHS use, citing high costs ...
England’s National Institute for Health and Care Excellence (NICE) has given a second thumbs down to a pair of Alzheimer’s ...
The Trump Administration reversed course on plans to terminate the lease of a major Food and Drug Administration quality lab ...
Congress did not reauthorize the rare pediatric disease priority review program at the end of 2024. Advocates say the ripple ...
MedPage Today on MSN7h
Humira Copycats for Psoriasis Backed by Real-World OutcomesTwo adalimumab biosimilars (Amjevita and Imraldi) worked as well for moderate to severe psoriasis as the original brand-name ...
Albemarle, Akamai Technologies, Global Payments, Dow, and Brown-Forman are trading at least 40% below fair value.
23h
Driven Diagnostics Fuels GrowthPune, March 06, 2025 (GLOBE NEWSWIRE) -- According to SNS Insider, The Digital Neuro Biomarkers Market in 2023 was valued at USD 538.96 million, and is expected to reach ...
Continuous fluctuations in America's trade policies continued to disrupt financial markets on Thursday with US stocks once ...
Sage Chief Medical Officer Laura Gault, M.D., Ph.D., is stepping down to pursue a new opportunity effective March 21, the ...
Latest update from the BOM shows cyclone likely to cross close to Moreton Bay ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback